Johnson & Johnson is a global healthcare conglomerate engaged in the research, development, and manufacture of pharmaceuticals, medical devices, and consumer health products. With a mission to improve health for humanity, J&J operates across three segments: Innovative Medicine, focusing on areas like oncology and immunology; MedTech, providing surgical and orthopedic solutions; and Consumer Health, offering products in baby care, skin health, and oral care. The company emphasizes innovation, sustainability, and global health equity, delivering solutions that impact millions worldwide.
Johnson & Johnson announces the FDA's committee vote supporting DARZALEX FASPRO to potentially delay or prevent progression in high-risk smoldering multiple myeloma.
